The changing landscape of systemic therapy in the treatment of synchronous metastatic hormone-sensitive prostate cancer

医学 醋酸阿比特龙酯 多西紫杉醇 前列腺癌 内科学 癌症 全身疗法 肿瘤科 雄激素剥夺疗法 乳腺癌
作者
Edward Lambert,Nicolaas Lumen,Valerie Fonteyne,Daan De Maeseneer,Sofie Verbeke,Geert Villeirs,Kathia De Man,Charles Van Praet
出处
期刊:Clinical Genitourinary Cancer [Elsevier BV]
标识
DOI:10.1016/j.clgc.2022.11.001
摘要

To describe the changes in systemic treatments (ST) of synchronous metastatic hormone-sensitive prostate cancer (mHSPC) patients in a "real-world" setting and to explore reasons why contemporary standard of care (SOC) was not administrated to the patient.Since 2014, we prospectively register mHSPCpatients. Patients were grouped in 4 time periods: group 1 (Time period 1, January 2014-July 2015), group 2 after introduction of docetaxel (Time period 2, August 2015-July 2017), group 3 after introduction of abiraterone acetate (Time period 3, August 2017-February 2018) and group 4 after introduction of apalutamide (Time period 4, March 2018-October 2021). For every time period, we evaluated the initiated additional ST. In case patients received treatment that differed from contemporary SOC according to guidelines, reasons for this difference were explored.In total, 243 patients were included. A progressive decline in ADT monotherapy from 85% to 29% over time was observed. The proportion of patients receiving additional STs increased from 34% to 59%. Forty percent of patients were not treated according to contemporary SOC, but this percentage varied strongly per time period (10%, 67%, 53%, and 32% from time period 1 to time period 4 respectively). Reasons for these variations were heterogenous and varied across the 4 time periods. Patients being unfit for treatment and treating physicians failing to consider additional STs were the most prevalent reasons. The proportion of patients unfit for additional ST decreased from 18% to 4% over time.Use of ADT monotherapy declined gradually after the introduction of additional systemic treatments. The proportion of patients unfit for additional ST declined as more treatments became available. Although compliance to SOC increased over time, these real-world data show that adherence to clinical practice guidelines remains suboptimal. Efforts should be made by clinicians to increase the adherence to practice guidelines.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI5应助科研通管家采纳,获得10
刚刚
刚刚
科研通AI2S应助科研通管家采纳,获得10
刚刚
酷波er应助科研通管家采纳,获得10
刚刚
刚刚
刀锋完成签到,获得积分10
1秒前
晚夜微雨发布了新的文献求助30
1秒前
Sspringni完成签到,获得积分10
2秒前
落后师关注了科研通微信公众号
2秒前
所所应助longwang采纳,获得10
4秒前
6秒前
韩雨桐发布了新的文献求助10
6秒前
7秒前
9秒前
晚夜微雨完成签到,获得积分20
9秒前
突突突发布了新的文献求助10
10秒前
完美世界应助cheesejiang采纳,获得10
11秒前
tangzl完成签到 ,获得积分10
13秒前
仲乔妹发布了新的文献求助10
13秒前
英俊的铭应助Hear采纳,获得10
13秒前
13秒前
wlp鹏完成签到,获得积分10
13秒前
ding应助CC采纳,获得10
15秒前
落后师发布了新的文献求助10
18秒前
18秒前
20秒前
21秒前
22秒前
DDDD发布了新的文献求助10
23秒前
润华发布了新的文献求助10
25秒前
longwang发布了新的文献求助10
26秒前
hanleiharry1发布了新的文献求助10
26秒前
27秒前
星叶完成签到 ,获得积分10
28秒前
28秒前
赘婿应助酷炫的背包采纳,获得10
30秒前
hanleiharry1完成签到,获得积分20
31秒前
夜雨发布了新的文献求助10
32秒前
LLXY发布了新的文献求助10
34秒前
星辰大海应助hwj524采纳,获得10
35秒前
高分求助中
Encyclopedia of Mathematical Physics 2nd edition 888
Technologies supporting mass customization of apparel: A pilot project 600
Introduction to Strong Mixing Conditions Volumes 1-3 500
Tip60 complex regulates eggshell formation and oviposition in the white-backed planthopper, providing effective targets for pest control 400
Optical and electric properties of monocrystalline synthetic diamond irradiated by neutrons 320
共融服務學習指南 300
Essentials of Pharmacoeconomics: Health Economics and Outcomes Research 3rd Edition. by Karen Rascati 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3803788
求助须知:如何正确求助?哪些是违规求助? 3348592
关于积分的说明 10339483
捐赠科研通 3064770
什么是DOI,文献DOI怎么找? 1682762
邀请新用户注册赠送积分活动 808409
科研通“疑难数据库(出版商)”最低求助积分说明 764096